Please assess the completion status of the following clinical trial:

Trial Title: Combined Apheresis for ABO-incompatible Transplantation - a Pilot Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Eligibility for living donor ABO-incompatible kidney transplantation according to center standard~* Age \>18 years~* Signed written informed consent~* Negative cytotoxic and flow-cytometric crossmatch~Exclusion Criteria:~* Age\<18 years~* No signed written informed consent~* Blood group AB (no isoagglutinins)~* Pregnant and breastfeeding women~* HLA-sensitized patients (i.e. patients with preformed antibodies against donor HLA antigens)~* Positive cytotoxic and flow-cytometric crossmatch~* Severe blood coagulation disorder precluding the use of membrane filtration or immunoadsorption~* Initial serum fibrinogen \<200mg/dL~* IgA deficiency~* Any severe disease (e.g. severe infection) precluding ABOi-KTX~* Heparin intolerance~* Polysulfone intolerance~* Participation in any other intervention trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Combined apheresis (Type: EXPERIMENTAL): Patients will be treated by semiselective immunoadsorption combined with membrane filtration

Based on this trial design, predict the completion outcome and termination type (if applicable).